| | | Deletion | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Deletion | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51L3-RFFL, RAD51D (G289fs +2 more) | Duplication (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Deletion | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Deletion | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51D, RAD51L3-RFFL (I281fs +2 more) | Duplication (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Deletion (stop lost +3 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51D, RAD51L3-RFFL (E121fs +2 more) | Duplication (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | GPathogenic/Likely pathogenic |
| | RAD51D, RAD51L3-RFFL (W156fs +2 more) | Deletion (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | | Deletion | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51D, RAD51L3-RFFL (A184fs +2 more) | Deletion (non-coding transcript variant +1 more) | not provided +1 more | GPathogenic/Likely pathogenic |
| | RAD51D, RAD51L3-RFFL (D144fs +2 more) | Deletion (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51D, RAD51L3-RFFL (G285fs +2 more) | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Deletion | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51D, RAD51L3-RFFL (I271fs +2 more) | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51D, RAD51L3-RFFL (L235fs +2 more) | Duplication (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51D, RAD51L3-RFFL (T204fs +2 more) | Duplication (frameshift variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | RAD51D, RAD51L3-RFFL (T97fs +2 more) | Duplication (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | GPathogenic/Likely pathogenic |
| | RAD51L3-RFFL, RAD51D (A209fs +2 more) | Microsatellite (frameshift variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (splice acceptor variant) | Hereditary breast ovarian cancer syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Deletion | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51D, RAD51L3-RFFL (G146fs +2 more) | Deletion (non-coding transcript variant +1 more) | not provided +2 more | GPathogenic/Likely pathogenic |
| | RAD51D, RAD51L3-RFFL (R279fs +2 more) | Duplication (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51L3-RFFL, RAD51D (Q301* +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51D, RAD51L3-RFFL (M263fs +2 more) | Duplication (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51L3-RFFL, RAD51D (R320fs +1 more) | Deletion (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | GPathogenic/Likely pathogenic |
| | RAD51D, RAD51L3-RFFL (R300* +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | GPathogenic/Likely pathogenic |